This is not the most recent version of the article. View current version (6 OCT 2010)

Intervention Protocol

Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion

  1. Tasanee ST Smith1,*,
  2. Afshan A Nanji2,
  3. Paul B Greenberg3

Editorial Group: Cochrane Eyes and Vision Group

Published Online: 16 JUL 2008

DOI: 10.1002/14651858.CD007325

Database Title

Additional Information

How to Cite

Smith TST, Nanji AA, Greenberg PB. Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD007325. DOI: 10.1002/14651858.CD007325.

Author Information

  1. 1

    Johns Hopkins Bloomberg School of Public Health, c/o Cochrane Eyes and Vision Group US Project, Baltimore, USA

  2. 2

    Johns Hopkins University, Dana Center for Preventive Ophthalmology, Baltimore, Maryland, USA

  3. 3

    Division of Ophthalmology, The Warren Alpert Medical School of Brown University, Department of Ophthalmology, Rhode Island Hospital, Providence, Rhode Island, USA

*Tasanee ST Smith, c/o Cochrane Eyes and Vision Group US Project, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, W5010, Baltimore, 21205, USA. tasaneesmith@doctors.org.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 16 JUL 2008

SEARCH

ARTICLE TOOLS

This is not the most recent version of the article.View current version (06 Oct 2010)

View Full Article (HTML) Full (165K)
 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The aim of this review is to investigate the effectiveness and safety of anti-VEGF therapies for the treatment of ME secondary to CRVO.

View Full Article (HTML) Full (165K)